Disease progression in relation to age at onset in a population with Alzheimer's Dementia.
Alzheimer’s Disease
Disease progression
Early- and late-onset
Journal
Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
13
04
2018
accepted:
17
08
2018
pubmed:
30
8
2018
medline:
8
6
2019
entrez:
30
8
2018
Statut:
ppublish
Résumé
One thousand and 679 Alzheimer's Disease patients (early onset EO: 152 and late onset LO: 1527) were evaluated after 12, 36 and 60 months. At baseline EO patients have higher Mini Mental State examination (MMSE) and fewer comorbidities in respect to LO group. The MMSE score did not significantly differ after 12, 36 and 60 months; a more marked worsening in instrumental daily activities was observed after 36 months in the EO compared with the LO group. These data allow to conclude that EO patients may have a slight faster progression in the disease within the first 3 years after the diagnosis, but in a longer follow-up no differences exist in respect to LO group. The literature failed to identify specific factors capable to influence the disease progression in AD. Our data are in substantial agreement with the literature and seem to confirm the great heterogeneity of AD patients.
Identifiants
pubmed: 30155799
doi: 10.1007/s40520-018-1027-5
pii: 10.1007/s40520-018-1027-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM